Answers are grounded in this paper and cite their sources.
Herpes simplex virus (HSV) causes a number of diseases and new therapies are being pursued vigorously. Earlier studies have shown that modified peptides based on lactoferricins reduce HSV-1 and HSV-2 infection, and structure-activity studies indicate that the anti-viral activity correlates with the binding affinity for heparan sulphate and chondroitin sulphate. In this study it is shown that theoretically derived amino acid descriptors can be used to model the anti-viral activity of peptides, as well as other peptide properties, even more accurately.
No takes yet. Share an insight, caveat, or question.
Jenssen et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: